Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > MY TAKE

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Oct 20, 2023 11:23am

215 Views

Post# 35693031

RE:MY TAKE

I can't agree with you more skys. Its defintely not too early for some sort of a royalty deal. Hopefully that would give us the cash to get as far as a phase 2 on another indication. My personal guess is should we have excellent results start to trickle in on another indication & a path to AA for bladder then we are in buyout territory.

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks